StopDownOpen the app

Launch

Serendipity tests satellite for drug-making in space

By ·

Date
Company
Serendipity
What it does
Pharmaceutical manufacturing in microgravity
Kind
Launch

What they do

Serendipity flight-tested a prototype satellite for pharmaceutical manufacturing under microgravity using a high-altitude balloon at TIFR Hyderabad facility

What happened

The satellite carries an autonomous pharmaceutical factory called 'Alchemy' designed to operate 400-500 km above Earth

Why it matters

The broader in-space manufacturing market is forecast to grow from $1.5 Bn in 2026 to $3.5 Bn by 2030

The details

  • Serendipity flight-tested a prototype satellite for pharmaceutical manufacturing under microgravity.
  • The test used a high-altitude balloon at the TIFR Hyderabad facility.
  • The satellite carries an autonomous pharmaceutical factory called 'Alchemy'.
  • Alchemy is designed to deploy 400-500 km above Earth and stay for weeks or months.
  • It can return with molecules via re-entry systems.

The bigger picture

  • Microgravity reduces convection, sedimentation, and buoyancy, allowing crystals to form with greater uniformity.
  • This is important for pharmaceutical manufacturing where crystal structure affects drug efficacy.
  • The pharmaceuticals-in-microgravity market was estimated at $768 Mn in 2024 and expected to grow to $3 Bn by 2033.
  • Drug crystallisation and protein-folding improvements are the strongest near-term pharma use cases for microgravity.

About the business

  • Serendipity builds satellites for pharmaceutical manufacturing in microgravity.
  • Its satellite carries an autonomous factory called Alchemy that operates in low Earth orbit.
  • The factory can stay in orbit for weeks or months and return molecules to Earth via re-entry systems.
  • The company targets pharmaceutical firms for microgravity applications.
  • Protein crystallisation for drug discovery is a key application.

Read it as a card in the app

Same day

All startup news on 26 August 2026 →